Circulating tumor DNA (ctDNA) dynamics during anti-PD-1 based therapy may predict clinical outcomes in advanced stage melanoma: a multicente Burkey et al. ASCO 2025 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen